Endpoints News

Known as a leading source for breaking news in the biopharma world, Endpoints News provides smart analysis and exclusive access. It covers the intersection of science, money, and power in the world's most innovative industry. As a part of the Financial Times' FT Specialist group, it has a significant influence in the industry.